156 related articles for article (PubMed ID: 33930008)
21. Improved risk-stratification for posterior fossa ependymoma of childhood considering clinical, histological and genetic features - a retrospective analysis of the HIT ependymoma trial cohort.
Jünger ST; Mynarek M; Wohlers I; Dörner E; Mühlen AZ; Velez-Char N; von Hoff K; Rutkowski S; Warmuth-Metz M; Kortmann RD; Timmermann B; Rahmann S; Klein-Hitpass L; von Bueren AO; Pietsch T
Acta Neuropathol Commun; 2019 Nov; 7(1):181. PubMed ID: 31727173
[TBL] [Abstract][Full Text] [Related]
22. Childhood ependymoma: a systematic review of treatment options and strategies.
Grill J; Pascal C; Chantal K
Paediatr Drugs; 2003; 5(8):533-43. PubMed ID: 12895136
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors and treatment options for paediatric ependymomas.
Vaidya K; Smee R; Williams JR
J Clin Neurosci; 2012 Sep; 19(9):1228-35. PubMed ID: 22840355
[TBL] [Abstract][Full Text] [Related]
24. Advances in Management of Pediatric Ependymomas.
Lin FY; Chintagumpala M
Curr Oncol Rep; 2015 Oct; 17(10):47. PubMed ID: 26369328
[TBL] [Abstract][Full Text] [Related]
25. Predictors of functional recovery in adults with posterior fossa ependymomas.
Mirzadeh Z; Bina R; Kusne Y; Coons SW; Spetzler RF; Sanai N
J Neurosurg; 2014 May; 120(5):1063-8. PubMed ID: 24579660
[TBL] [Abstract][Full Text] [Related]
26. Anaplastic ependymoma: treatment of pediatric patients with or without craniospinal radiation therapy.
Merchant TE; Haida T; Wang MH; Finlay JL; Leibel SA
J Neurosurg; 1997 Jun; 86(6):943-9. PubMed ID: 9171172
[TBL] [Abstract][Full Text] [Related]
27. Combined treatment of fourth ventricle ependymomas: report of 26 cases.
Spagnoli D; Tomei G; Ceccarelli G; Grimoldi N; Lanterna A; Bello L; Sinisi MM; De Santis A; Villani RM
Surg Neurol; 2000 Jul; 54(1):19-26; discussion 26. PubMed ID: 11024503
[TBL] [Abstract][Full Text] [Related]
28. Is gross-total resection sufficient treatment for posterior fossa ependymomas?
Rogers L; Pueschel J; Spetzler R; Shapiro W; Coons S; Thomas T; Speiser B
J Neurosurg; 2005 Apr; 102(4):629-36. PubMed ID: 15871504
[TBL] [Abstract][Full Text] [Related]
29. Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group.
Robertson PL; Zeltzer PM; Boyett JM; Rorke LB; Allen JC; Geyer JR; Stanley P; Li H; Albright AL; McGuire-Cullen P; Finlay JL; Stevens KR; Milstein JM; Packer RJ; Wisoff J
J Neurosurg; 1998 Apr; 88(4):695-703. PubMed ID: 9525716
[TBL] [Abstract][Full Text] [Related]
30. Heterogeneity within the PF-EPN-B ependymoma subgroup.
Cavalli FMG; Hübner JM; Sharma T; Luu B; Sill M; Zapotocky M; Mack SC; Witt H; Lin T; Shih DJH; Ho B; Santi M; Emery L; Hukin J; Dunham C; McLendon RE; Lipp ES; Gururangan S; Grossbach A; French P; Kros JM; van Veelen MC; Rao AAN; Giannini C; Leary S; Jung S; Faria CC; Mora J; Schüller U; Alonso MM; Chan JA; Klekner A; Chambless LB; Hwang EI; Massimino M; Eberhart CG; Karajannis MA; Lu B; Liau LM; Zollo M; Ferrucci V; Carlotti C; Tirapelli DPC; Tabori U; Bouffet E; Ryzhova M; Ellison DW; Merchant TE; Gilbert MR; Armstrong TS; Korshunov A; Pfister SM; Taylor MD; Aldape K; Pajtler KW; Kool M; Ramaswamy V
Acta Neuropathol; 2018 Aug; 136(2):227-237. PubMed ID: 30019219
[TBL] [Abstract][Full Text] [Related]
31. Telomerase activation in posterior fossa group A ependymomas is associated with dismal prognosis and chromosome 1q gain.
Gojo J; Lötsch D; Spiegl-Kreinecker S; Pajtler KW; Neumayer K; Korbel P; Araki A; Brandstetter A; Mohr T; Hovestadt V; Chavez L; Kirchhofer D; Ricken G; Stefanits H; Korshunov A; Pfister SM; Dieckmann K; Azizi AA; Czech T; Filipits M; Kool M; Peyrl A; Slavc I; Berger W; Haberler C
Neuro Oncol; 2017 Sep; 19(9):1183-1194. PubMed ID: 28371821
[TBL] [Abstract][Full Text] [Related]
32. Suprasellar giant cell ependymoma: a rare neoplasm in a unique location.
Sangoi AR; Lim M; Dulai M; Vogel H; Chang S
Hum Pathol; 2008 Sep; 39(9):1396-401. PubMed ID: 18602668
[TBL] [Abstract][Full Text] [Related]
33. Intracranial ependymoma long term outcome, patterns of failure.
Kovalic JJ; Flaris N; Grigsby PW; Pirkowski M; Simpson JR; Roth KA
J Neurooncol; 1993 Feb; 15(2):125-31. PubMed ID: 8509817
[TBL] [Abstract][Full Text] [Related]
34. Distinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomas.
Godfraind C; Kaczmarska JM; Kocak M; Dalton J; Wright KD; Sanford RA; Boop FA; Gajjar A; Merchant TE; Ellison DW
Acta Neuropathol; 2012 Aug; 124(2):247-57. PubMed ID: 22526017
[TBL] [Abstract][Full Text] [Related]
35. Metastatic ependymoma: a multi-institutional retrospective analysis of prognostic factors.
Zacharoulis S; Ji L; Pollack IF; Duffner P; Geyer R; Grill J; Schild S; Jaing TH; Massimino M; Finlay J; Sposto R
Pediatr Blood Cancer; 2008 Feb; 50(2):231-5. PubMed ID: 17610266
[TBL] [Abstract][Full Text] [Related]
36. Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors.
Fukuoka K; Kanemura Y; Shofuda T; Fukushima S; Yamashita S; Narushima D; Kato M; Honda-Kitahara M; Ichikawa H; Kohno T; Sasaki A; Hirato J; Hirose T; Komori T; Satomi K; Yoshida A; Yamasaki K; Nakano Y; Takada A; Nakamura T; Takami H; Matsushita Y; Suzuki T; Nakamura H; Makino K; Sonoda Y; Saito R; Tominaga T; Matsusaka Y; Kobayashi K; Nagane M; Furuta T; Nakada M; Narita Y; Hirose Y; Ohba S; Wada A; Shimizu K; Kurozumi K; Date I; Fukai J; Miyairi Y; Kagawa N; Kawamura A; Yoshida M; Nishida N; Wataya T; Yamaoka M; Tsuyuguchi N; Uda T; Takahashi M; Nakano Y; Akai T; Izumoto S; Nonaka M; Yoshifuji K; Kodama Y; Mano M; Ozawa T; Ramaswamy V; Taylor MD; Ushijima T; Shibui S; Yamasaki M; Arai H; Sakamoto H; Nishikawa R; Ichimura K;
Acta Neuropathol Commun; 2018 Dec; 6(1):134. PubMed ID: 30514397
[TBL] [Abstract][Full Text] [Related]
37. Survival and functional outcomes of molecularly defined childhood posterior fossa ependymoma: Cure at a cost.
Zapotocky M; Beera K; Adamski J; Laperierre N; Guger S; Janzen L; Lassaletta A; Figueiredo Nobre L; Bartels U; Tabori U; Hawkins C; Urbach S; Tsang DS; Dirks PB; Taylor MD; Bouffet E; Mabbott DJ; Ramaswamy V
Cancer; 2019 Jun; 125(11):1867-1876. PubMed ID: 30768777
[TBL] [Abstract][Full Text] [Related]
38. EZHIP: a new piece of the puzzle towards understanding pediatric posterior fossa ependymoma.
Jenseit A; Camgöz A; Pfister SM; Kool M
Acta Neuropathol; 2022 Jan; 143(1):1-13. PubMed ID: 34762160
[TBL] [Abstract][Full Text] [Related]
39. Craniospinal irradiation as part of re-irradiation for children with recurrent intracranial ependymoma.
Tsang DS; Murray L; Ramaswamy V; Zapotocky M; Tabori U; Bartels U; Huang A; Dirks PB; Taylor MD; Hawkins C; Bouffet E; Laperriere N
Neuro Oncol; 2019 Mar; 21(4):547-557. PubMed ID: 30452715
[TBL] [Abstract][Full Text] [Related]
40. A retrospective analysis of recurrent pediatric ependymoma reveals extremely poor survival and ineffectiveness of current treatments across central nervous system locations and molecular subgroups.
Ritzmann TA; Rogers HA; Paine SML; Storer LCD; Jacques TS; Chapman RJ; Ellison D; Donson AM; Foreman NK; Grundy RG
Pediatr Blood Cancer; 2020 Sep; 67(9):e28426. PubMed ID: 32614133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
